JPWO2019169153A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019169153A5
JPWO2019169153A5 JP2020545526A JP2020545526A JPWO2019169153A5 JP WO2019169153 A5 JPWO2019169153 A5 JP WO2019169153A5 JP 2020545526 A JP2020545526 A JP 2020545526A JP 2020545526 A JP2020545526 A JP 2020545526A JP WO2019169153 A5 JPWO2019169153 A5 JP WO2019169153A5
Authority
JP
Japan
Prior art keywords
oxy
propanamide
dimethyl
pyridin
trifluoromethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020545526A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021515004A (ja
JP2021515004A5 (https=
JP7297776B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/020086 external-priority patent/WO2019169153A1/en
Publication of JP2021515004A publication Critical patent/JP2021515004A/ja
Publication of JP2021515004A5 publication Critical patent/JP2021515004A5/ja
Publication of JPWO2019169153A5 publication Critical patent/JPWO2019169153A5/ja
Priority to JP2023098091A priority Critical patent/JP2023134444A/ja
Application granted granted Critical
Publication of JP7297776B2 publication Critical patent/JP7297776B2/ja
Priority to JP2025016827A priority patent/JP2025084759A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020545526A 2018-03-01 2019-02-28 ピペリジニル－３－（アリールオキシ）プロパンアミド及びプロパノエート Active JP7297776B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023098091A JP2023134444A (ja) 2018-03-01 2023-06-14 ピペリジニル－３－（アリールオキシ）プロパンアミド及びプロパノエート
JP2025016827A JP2025084759A (ja) 2018-03-01 2025-02-04 ピペリジニル－３－（アリールオキシ）プロパンアミド及びプロパノエート

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862637295P 2018-03-01 2018-03-01
US62/637,295 2018-03-01
PCT/US2019/020086 WO2019169153A1 (en) 2018-03-01 2019-02-28 Piperidinyl-3-(aryloxy)propanamides and propanoates

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023098091A Division JP2023134444A (ja) 2018-03-01 2023-06-14 ピペリジニル－３－（アリールオキシ）プロパンアミド及びプロパノエート

Publications (4)

Publication Number Publication Date
JP2021515004A JP2021515004A (ja) 2021-06-17
JP2021515004A5 JP2021515004A5 (https=) 2022-03-10
JPWO2019169153A5 true JPWO2019169153A5 (https=) 2022-03-10
JP7297776B2 JP7297776B2 (ja) 2023-06-26

Family

ID=65763866

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020545526A Active JP7297776B2 (ja) 2018-03-01 2019-02-28 ピペリジニル－３－（アリールオキシ）プロパンアミド及びプロパノエート
JP2023098091A Pending JP2023134444A (ja) 2018-03-01 2023-06-14 ピペリジニル－３－（アリールオキシ）プロパンアミド及びプロパノエート
JP2025016827A Pending JP2025084759A (ja) 2018-03-01 2025-02-04 ピペリジニル－３－（アリールオキシ）プロパンアミド及びプロパノエート

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023098091A Pending JP2023134444A (ja) 2018-03-01 2023-06-14 ピペリジニル－３－（アリールオキシ）プロパンアミド及びプロパノエート
JP2025016827A Pending JP2025084759A (ja) 2018-03-01 2025-02-04 ピペリジニル－３－（アリールオキシ）プロパンアミド及びプロパノエート

Country Status (22)

Country Link
US (3) US11045457B2 (https=)
EP (1) EP3759094A1 (https=)
JP (3) JP7297776B2 (https=)
KR (2) KR20250094741A (https=)
CN (1) CN112236423B (https=)
AR (1) AR114421A1 (https=)
AU (1) AU2019228568B2 (https=)
BR (1) BR112020017644A2 (https=)
CA (1) CA3092450A1 (https=)
CL (1) CL2020002257A1 (https=)
EA (1) EA202092054A1 (https=)
EC (1) ECSP20062464A (https=)
IL (1) IL276998B2 (https=)
MX (1) MX2020009062A (https=)
MY (1) MY206763A (https=)
PE (1) PE20211313A1 (https=)
PH (1) PH12020551359A1 (https=)
SG (1) SG11202008398XA (https=)
TW (1) TWI834637B (https=)
UA (1) UA126829C2 (https=)
WO (1) WO2019169153A1 (https=)
ZA (1) ZA202005438B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI834637B (zh) * 2018-03-01 2024-03-11 日商武田藥品工業有限公司 六氫吡啶基-3-(芳氧基)丙醯胺及丙酸酯
GB201901559D0 (en) * 2019-02-05 2019-03-27 Syngenta Crop Protection Ag Herbicidal compositions
CN114867720B (zh) 2020-01-16 2024-10-22 浙江海正药业股份有限公司 杂芳基类衍生物及其制备方法和用途
AR121682A1 (es) * 2020-03-31 2022-06-29 Takeda Pharmaceuticals Co Derivados de n-(heterociclil y heterociclilalquil)-3-bencilpiridin-2-amina como agonistas de sstr4
AR121683A1 (es) * 2020-03-31 2022-06-29 Takeda Pharmaceuticals Co Derivados de n-heteroarilalquil-2-(heterociclil y heterociclilmetil)acetamida como agonistas de sstr4
CN113717161B (zh) * 2020-05-21 2023-06-09 广州费米子科技有限责任公司 含氮饱和杂环化合物及其制备方法、药物组合物和应用
US20240217913A2 (en) * 2020-08-24 2024-07-04 Hua Medicine (Shanghai) Ltd. Preparation of substituted acrylate compound
US20240208923A1 (en) 2021-03-10 2024-06-27 Jnana Therapeutics Inc. Small molecule inhibitors of mammalian slc6a19 function
CN115477640A (zh) * 2021-05-31 2022-12-16 由理生物医药（上海）有限公司 作为parp7抑制剂的哒嗪酮类化合物
IL315998A (en) * 2022-03-30 2024-11-01 Takeda Pharmaceuticals Co N-(pyrrolidin-3-yl or piperidin-4-yl)acetamide derivatives
WO2025247982A1 (en) 2024-05-29 2025-12-04 Grünenthal GmbH Piperazines which act as sstr4 modulators

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
GB9518953D0 (en) 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
SE9902987D0 (sv) 1999-08-24 1999-08-24 Astra Pharma Prod Novel compounds
CN1960970A (zh) * 2004-05-28 2007-05-09 田边制药株式会社 作为cb1受体的拮抗剂的吡咯烷衍生物
TW200602314A (en) 2004-05-28 2006-01-16 Tanabe Seiyaku Co A novel pyrrolidine compound and a process for preparing the same
US8258305B2 (en) 2005-02-23 2012-09-04 Prexa Pharmaceuticals, Inc. Dopamine transporter inhibitors for use in treatment of movement disorders and other CNS indications
EP1893603B1 (en) 2005-06-02 2009-10-14 F. Hoffmann-La Roche AG Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists
JP4943826B2 (ja) * 2005-11-25 2012-05-30 田辺三菱製薬株式会社 医薬組成物
JP5736098B2 (ja) 2007-08-21 2015-06-17 アッヴィ・インコーポレイテッド 中枢神経系障害を治療するための医薬組成物
CA2718038A1 (en) 2008-03-14 2009-09-17 Exelixis, Inc. Azabicyclo [3.2.1] octyl derivatives as 11 beta-hsd1 modulators
WO2010059922A1 (en) 2008-11-21 2010-05-27 Ligand Pharmaceuticals Incorporated Pyrrolidine carboxamide compounds
CA2771568A1 (en) 2009-09-04 2011-03-10 Novartis Ag Heteroaryl compounds as kinase inhibitors
US9371282B2 (en) 2013-05-17 2016-06-21 Centrexion Therapeutics Corporation Somatostatin receptor subtype 4 (SSTR4) agonists
EP3045448A4 (en) * 2013-09-12 2017-01-25 Sumitomo Chemical Company Limited Nitrogen-containing saturated heterocyclic compound
CA2965566A1 (en) 2014-11-14 2016-05-19 Boehringer Ingelheim International Gmbh Morpholine and 1,4-oxazepane amides as somatostatin receptor subtype 4 (sstr4) agonists
WO2017003723A1 (en) * 2015-07-01 2017-01-05 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
TWI834637B (zh) * 2018-03-01 2024-03-11 日商武田藥品工業有限公司 六氫吡啶基-3-(芳氧基)丙醯胺及丙酸酯

Similar Documents

Publication Publication Date Title
JP2021515004A5 (https=)
IL276998B2 (en) Piperidinyl-3-(aryloxy)propanamides and propanoates
JP2007519754A5 (https=)
JP2010538076A5 (https=)
US8431599B2 (en) 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity
JP2004504301A5 (https=)
JPWO2019169153A5 (https=)
RU2356893C2 (ru) Ингибиторы фосфодиэстеразы 4
JP2004506718A5 (https=)
JP2019533694A5 (https=)
JP2021512143A5 (https=)
RU2010110640A (ru) Соединения и композиции 5-(4-(галогеналкокси)фенил)пиримидин-2-амина в качестве ингибиторов киназ
HRP20210143T1 (hr) 2-heteroaril-3-okso-2,3-dihidropiridazin-4-karboksamidi za liječenje raka
JP2013505969A5 (https=)
JP2004529931A5 (https=)
JP2013533279A5 (https=)
CA2601508A1 (en) Cyclopropanecarboxamide derivatives
JP2017511794A5 (https=)
RU2018104868A (ru) 2-амино-3-фтор-3-(фторметил)-6-метил-6-фенил-3,4,5,6-тетрагидропиридины в качестве ингибиторов bace1
CN102686572A (zh) 用于治疗cns病的噁唑啉衍生物
JP2016514711A5 (https=)
JP2006510609A5 (https=)
RU2016132858A (ru) Производные фторнафтила
RU2017104264A (ru) 2-окса-5-азабицикло[2.2.1]гептан-3-ильные производные
JP2020503302A5 (https=)